Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D )
NCT06522282 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600
Last updated 2024-10-01
Summary
To compare the prognosis of patients with hyperacute ischemic stroke (arriving at the emergency department between 4.5-6 hours of symptom onset) managed in a standard stroke unit adherent to guidelines versus managed in Emergency Stroke Unit (a new stroke unit based on low-field magnetic resonance imaging).
Conditions
- Ischemic Stroke, Acute
Interventions
- COMBINATION_PRODUCT
-
Emergency Stroke Unit based on 0.23-T MRI
The participants with hyperacute ischemic stroke (arriving at the emergency department between 4.5-6 hours of symptom onset) who are eligible to receive reperfusion therapy will be managed by Emergency Stroke Unit process based on low-field magnetic resonance imaging.
- COMBINATION_PRODUCT
-
Standard stroke unit
The participants with hyperacute ischemic stroke (arriving at the emergency department between 4.5-6 hours of symptom onset) who are eligible to receive reperfusion therapy will be managed by standard stroke unit process adherent to guidelines.
Sponsors & Collaborators
-
Beijing Tiantan Hospital
lead OTHER
Principal Investigators
-
Yongjun Wang · Beijing Tiantan Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-10
- Primary Completion
- 2025-12-01
- Completion
- 2026-03-01
Countries
- China
Study Locations
More Related Trials
-
The Androtriol Injection for the Treatment of Acute Ischemic Stroke
NCT06679322 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism
NCT03090113 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness and Safety of Edaravone Dexborneol in Acute Ischemic Stroke
NCT05644223 ·Status: UNKNOWN
-
Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke
NCT04950790 ·Status: UNKNOWN ·Phase: PHASE4
-
The Prehospital Administration of Normobaric Oxygen in Suspected Stroke
NCT05351073 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
NCT02430350 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of 5G-Mobile Stroke Unit With Standard EMS for Acute Ischemic Stroke
NCT06943885 ·Status: RECRUITING ·Phase: NA
-
The Effect of GD-iExo-003 in Acute Ischemic Stroke
NCT06138210 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study on the Role of Human Serum Albumin in Large Acute Ischemic Stroke of Anterior Circulation After Thrombectomy
NCT06629116 ·Status: RECRUITING ·Phase: NA
-
The Role of Hyperoxia in Acute Ischemic Stroke
NCT03904017 ·Status: TERMINATED ·Phase: NA
-
BUN/Cr-based Hydration Therapy to Improve Outcomes for Dehydrated Patients With Acute Ischemic Stroke.
NCT02099383 ·Status: COMPLETED ·Phase: PHASE3
-
Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window
NCT05634382 ·Status: UNKNOWN ·Phase: PHASE3
-
Predictive Study of Serum Endocan for Hemorrhagic Transformation After Reperfusion Therapies in Acute Ischemic Stroke
NCT05228080 ·Status: UNKNOWN
-
Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke
NCT00283088 ·Status: COMPLETED ·Phase: PHASE1
-
BXOS110 Injection in the Treatment of Acute Ischaemic Stroke
NCT06322394 ·Status: RECRUITING ·Phase: PHASE2
-
Ultrasound for Acute Field Triage of Stroke
NCT05845203 ·Status: UNKNOWN ·Phase: NA
-
Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
NCT06010628 ·Status: RECRUITING ·Phase: PHASE4
-
Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke
NCT03620370 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke
NCT06645522 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
NCT07263308 ·Status: RECRUITING ·Phase: PHASE3
-
Compound Edaravone Injection for Acute Ischemic Stroke
NCT01929096 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease
NCT06674460 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)
NCT07119021 ·Status: RECRUITING ·Phase: PHASE4
-
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II
NCT04516993 ·Status: COMPLETED ·Phase: PHASE2